Purine metabolism in childhood acute lymphoblastic leukemia: Biochemical markers for diagnosis and chemotherapy
β Scribed by J.P.R.M. van Laarhoven; G.Th. Spierenburg; J.A.J.M. Bakkeren; T.J. Schouten; C.H.M.M. De Bruyn; S.J. Geerts; E.D.A.M. Schretlen
- Book ID
- 113238232
- Publisher
- Elsevier Science
- Year
- 1983
- Tongue
- English
- Weight
- 929 KB
- Volume
- 7
- Category
- Article
- ISSN
- 0145-2126
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
## BACKGROUND. Cranial radiation therapy (CRT) has been suggested to be a principal factor responsible for long term neurocognitive deficits in survivors of acute lymphoblastic leukemia (ALL). However, neither reduction of the irradiation dose nor the elimination of irradiation entirely appear to h
Two groups of children with refractory acute lymphoblastic leukemia were treated with a regimen of methotrexate (MTX) and asparaginase (Asn'ase) based on studies of the effect of MTX in vitro on human lymphoblasts exposed to Asn'ase. Induction therapy in 12 children produced 4 complete remissions, 3
## Abstract A series of 14 children with bone marrow or testicular recurrence of acute lymphoblastic leukemia (ALL) and treated with pulsed combined chemotherapy incorporating doxorubicin is reviewed. All had been previously adequately treated according to established leukemia protocols. Median dis
## Abstract ## Background Antimetaboliteβbased continuation therapy is commonly used for childhood acute lymphoblastic leukemia (ALL) and hypoglycemia after prolonged fasting has been recently reported. We have found that spontaneous, symptomatic hypoglycemia (SH) may also occur in such patients.